This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.TM Hooton , WE Stamm . Diagnosis and treatment of uncomplicated urinary tract infection. Infectious Disease Clinics of North America 1997; 11: 551–581.
2.TA Russo , JR Johnson . Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes and Infection 2003; 5: 449–456.
4.B Foxman , Urinary tract infections: self-reported incidence and associated costs. Annals of Epidemiology 2000; 10: 509–515.
5.B Foxman . Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. American Journal of Medicine 2002; 113 (Suppl. 1A): 5S–13S.
6.S Yamamoto , Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. Journal of Urology 1997; 157: 1127–1129.
8.TM Hooton , A prospective study of risk factors for symptomatic urinary tract infection in young women. New England Journal of Medicine 1996; 335: 468–474.
9.PD Brown , B Foxman . Pathogenesis of urinary tract infection: the role of sexual behavior and sexual transmission. Current Infectious Disease Reports 2000; 2: 513–517.
10.B Foxman , RR Frerichs . Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. American Journal of Public Health 1985; 75: 1308–1313.
11.MC Kelsey , Relationship between sexual intercourse and urinary-tract infection in women attending a clinic for sexually transmitted diseases. Journal of Medical Microbiology 1979; 12: 511–512.
12.SN Shrikhande , CA Chande , AA Pathak . Virulence factors in uropathogenic E. coli. Indian Journal of Pathology and Microbiology 1999; 42: 321–325.
14.JDD Pitout , Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary Health Region. Journal of Clinical Microbiology 2005; 43: 2844–2849.
15.B Olesen , Cluster of multiresistant Escherichia coli O78:H10 in Greater Copenhagen. Scandinavian Journal of Infectious Diseases 1994; 26: 406–410.
16.AR Manges , Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. New England Journal of Medicine 2001; 345: 1007–1013.
17.JR Johnson , A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 2002; 359: 2249–2251.
18.AR Manges , PS Dietrich , LW Riley . Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clinical Infectious Diseases 2004; 38: 329–334.
19.AR Manges , Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections. Journal of Infection 2006; 53: 25–29.
20.FM Aarestrup , Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal Enterococci from food animals in Denmark. Antimicrobial Agents and Chemotherapy 2001; 45: 2054–2059.
21.JR Johnson , Antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in retail foods. Journal of Infectious Diseases 2005; 191: 1040–1049.
22.JR Johnson , Contamination of retail foods, particularly turkey, from community markets (Minnesota, 1999–2000) with antimicrobial-resistant and extraintestinal pathogenic Escherichia coli. Foodborne Pathogens and Disease 2005; 2: 38–49.
23.CM Schroeder , Isolation of antimicrobial-resistant Escherichia coli from retail meats purchased in Greater Washington, DC, USA. International Journal of Food Microbiology 2003; 85: 197–202.
24.C Vincent , Food reservoir for Escherichia coli causing urinary tract infections. Emerging Infectious Diseases 2010; 16: 88–95.
26.DJ Waghorn , TW Kelly , W Gibbins . Epidemic multi-resistant Escherichia coli infection in south London. Journal of Hospital Infection 1988; 11: 192–193.
28.CM Kunin , Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis. Clinical Infectious Diseases 1993; 16: 412–416.
29.JR Johnson , P Delavari , TT O'Bryan . Escherichia coli O18:K1:H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. Journal of Infectious Diseases 2001; 183: 425–434.
30.SY Tartof , Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. Journal of Clinical Microbiology 2005; 43: 5860–5864.
31.AR Manges , The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiology and Infection 2006; 134: 425–431.
32.JD Pitout , Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. Journal of Antimicrobial Chemotherapy 2005; 56: 52–59.
33.J Oteo , Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. Journal of Clinical Microbiology 2006; 44: 2359–2366.
34.N Mendonca , Spread of extended-spectrum beta-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial Agents and Chemotherapy 2007; 51: 1946–1955.
35.J Vranes , Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region. International Journal of Antimicrobial Agents 2008; 31 (Suppl. 1): S19–S24.
36.SH Lau , Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. Journal of Clinical Microbiology 2008; 46: 1076–1080.
37.N Woodford , Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. Journal of Antimicrobial Chemotherapy 2004; 54: 735–743.
38.JD Pitout , Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy 2005; 49: 4667–4670.
39.JD Pitout , Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrobial Agents and Chemotherapy 2007; 51: 1281–1286.
40.MH Nicolas-Chanoine , Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2008; 61: 273–281.
41.E Karisik , Differential expression of CTX-M-15 Beta-lactamase between two major Escherichia coli strains responsible for outbreaks in the UK. Proceedings of 16th European Congress of Clincal Microbiology and Infectious Diseases, Nice, 2006.
43.E Karisik , Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum β-lactamases in the UK. Journal of Antimicrobial Chemotherapy 2008; 61: 54–58.
44.M Blanco , Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. Journal of Antimicrobial Chemotherapy 2009; 63: 1135–1141.
46.JR Johnson . Virulence factors in Escherichia coli urinary tract infection. Clinical Microbiology Reviews 1991; 4: 80–128.
47.KL Vosti . Infections of the urinary tract in women: a prospective, longitudinal study of 235 women observed for 1–19 years. Medicine 2002; 81: 369–387.
49.JT Freeman , DJ Anderson , DJ Sexton . Seasonal peaks in Escherichia coli infections: possible explanations and implications. Clinical Microbiology and Infection 2009; 15: 951–953.
50.MN Al-Hasan . Seasonal variation in Escherichia coli bloodstream infection: a population-based study. Clinical Microbiology and Infection 2009; 15: 947–950.
51.JE Anderson . Seasonality of symptomatic bacterial urinary infections in women. Journal of Epidemiology and Community Health 1983; 37: 286–290.
52.G Prats , Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerging Infectious Diseases 2003; 9: 1273–1280.
53.LA Rantz . Serological grouping of Escherichia coli. Study in urinary tract infection. Archives of Internal Medicine 1962; 109: 37–42.
56.WT Wong , KA Bettelheim . Escherichia coli isolated from urinary tract infections in Hong Kong, 1969 to 1976. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene A 1981; 251: 279–283.
57.WR Gransden , Bacteremia due to Escherichia coli: a study of 861 episodes. Reviews of Infectious Diseases 1990; 12: 1008–1018.
58.WR McCabe , Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. Journal of Infectious Diseases 2007; 138: 33–41.
60.JF van den Bosch , Virulence of Escherichia coli strains isolated from urine of patients with acute cystitis and from faeces of healthy women. Antonie Van Leeuwenhoek 1981; 47: 97–106.
62.G Otto , Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clinical Infectious Diseases 1993; 17: 448–456.
63.JF van den Bosch , Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination. Journal of Hygiene 1982; 88: 567–577.
64.P Ulleryd , Virulence characteristics of Escherichia coli in relation to host response in men with symptomatic urinary tract infection. Clinical Infectious Diseases 1994; 18: 579–584.
65.B Olesen , A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. Journal of Hospital Infections 1995; 31: 295–304.
67.JR Johnson , JJ Brown , JN Maslow . Clonal distribution of the three alleles of the Gal(alpha1-4)Gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia. Journal of Infectious Diseases 1998; 177: 651–661.
68.M Blanco , Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. European Journal of Epidemiology 1996; 12: 191–198.
69.M Katouli , Virulence characteristics of Escherichia coli strains causing acute cystitis in young adults in Iran. Journal of Infection 2005; 50: 312–321.
70.JR Johnson , Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clinical Infectious Diseases 2005; 40: 813–822.
71.JR Johnson , Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. Journal of Clinical Microbiology 2005; 43: 6064–6072.
72.A Andreu , Urovirulence determinants in Escherichia coli strains causing prostatitis. Journal of Infectious Diseases 1997; 176: 464–469.
73.A Terai , Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. International Journal of Urology 1997; 4: 289–294.
74.JR Johnson , papG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. Journal of Infectious Diseases 1998; 177: 97–101.
75.B Olesen , Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes. Journal of Infection 1998; 36: 93–100.
76.M Ananias , T Yano . Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Brazilian Journal of Medical and Biological Research 2008; 41: 877–883.
77.D Moher , Preferred Reporting Items for Systematic reviews and Meta-Analyses: the PRISMA Statement. PLoS Medicine 2009; 6: e1000097.